Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CCM Pharmaceuticals, a core subsidiary of Duopharma Biotech Berhad, is a leading Malaysian pharmaceutical company focused on the development, manufacturing, and commercialization of generic drugs and consumer health products. The company maintains a dominant position in the Southeast Asian market, offering a broad portfolio that spans therapeutic areas such as cardiovascular health, diabetes, oncology, and respiratory medicine. CCM Pharmaceuticals is well-known for its iconic over-the-counter brands, including Flavettes and Champs, which are household names in Malaysia. In addition to its generics business, the company has expanded into specialty biologics and biosimilars through strategic international partnerships. Operating multiple GMP-certified manufacturing facilities, CCM Pharmaceuticals provides high-quality pharmaceutical solutions to both the public and private healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CCM Pharma.